FGFR3 signaling and function in triple negative breast cancer.

Nicole J ChewElizabeth V NguyenShih-Ping SuKarel NovyHoward C ChanLan K NguyenJennii LuuKaylene J SimpsonRachel S LeeRoger J Daly

Published in: Cell communication and signaling : CCS (2020)

These results indicate that targeting FGFR3 may represent a therapeutic option for TNBC, but only for patients with oncogenic FGFR3 alterations, such as the FGFR3-TACC3 fusion. Video abstract.

Keyphrases

cancer therapy